Oncology & Cancer

Optimizing balance of treatments in prostate cancer

Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy. The ideal duration of treatment may be roughly two years if receiving external beam radiation and one year ...

Oncology & Cancer

Scientists target protein to lower risk of prostate cancer spread

Targeting a specific protein that is often overexpressed in prostate cancer can help prevent or delay the disease from spreading to other parts of the body, according to a study led by Cedars-Sinai Cancer investigators.

Oncology & Cancer

Genetic clues link lipoprotein A to prostate cancer risk

A new analysis has uncovered a potential link between higher prostate cancer risk and genetic variants associated with higher bloodstream levels of the cholesterol-transporting molecule lipoprotein A. Anna Ioannidou of Imperial ...

page 10 from 40